Toronto Dominion Bank Bria Cell Therapeutics Corp. Transaction History

Toronto Dominion Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$4.28 - $11.9 $325 - $904	76 New	76 $1,000
Q1 2022 May 09, 2022	SELL	$5.91 - $10.14 $230 - $395	-39 Closed	0 $0
Q4 2021 Feb 04, 2022	BUY	$7.1 - $10.61 $255 - $381	36 Added 1200.0%	39 $0
Q3 2021 Nov 08, 2021	SELL	$4.4 - $9.28 $3,691 - $7,785	-839 Reduced 99.64%	3 $0
Q2 2021 Aug 13, 2021	BUY	$2.89 - $6.57 $2,433 - $5,531	842 New	842 $5,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $16M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.